Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brunangelo Falini

Showing results (221-230 of 246) with videos related to

Pageof 25
Sort By:
Nature Genetics|October 2, 2019
Germline NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenitaDaphna Nachmani, Anne H Bothmer, Silvia Grisendi, et al.
Blood|August 3, 2021
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AMLMaria Paola Martelli, Roberta Rossi, Alessandra Venanzi, et al.
Haematologica|November 2, 2018
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic targetMaria Rosaria Sapienza, Francesco Abate, Federica Melle, et al.
Blood|May 25, 2006
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli, Niccolò Bolli, et al.
Hemasphere|November 17, 2025
Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R)Luca De Carolis, Monia Capponi, Andrea Bernardelli, et al.
Blood|December 12, 2022
Overlapping features of therapy-related and de novo NPM1-mutated AMLJad Othman, Manja Meggendorfer, Enrico Tiacci, et al.
The New England Journal of Medicine|June 14, 2011
BRAF mutations in hairy-cell leukemiaEnrico Tiacci, Vladimir Trifonov, Gianluca Schiavoni, et al.
Blood Cancer Journal|July 19, 2022
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian studyLivio Pagano, Marianna Criscuolo, Alessandro Broccoli, et al.
Haematologica|August 29, 2020
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06Chiara Caprioli, Federico Lussana, Silvia Salmoiraghi, et al.
Haematologica|December 24, 2002
Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patientsPier Luigi Zinzani, Maurizio Martelli, Marilena Bertini, et al.
Pageof 25

Showing results (221-230 of 246) with videos related to

Sort By:
Pageof 25
Nature Genetics|October 2, 2019
Germline NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenitaDaphna Nachmani, Anne H Bothmer, Silvia Grisendi, et al.
Blood|August 3, 2021
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AMLMaria Paola Martelli, Roberta Rossi, Alessandra Venanzi, et al.
Haematologica|November 2, 2018
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic targetMaria Rosaria Sapienza, Francesco Abate, Federica Melle, et al.
Blood|May 25, 2006
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli, Niccolò Bolli, et al.
Hemasphere|November 17, 2025
Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R)Luca De Carolis, Monia Capponi, Andrea Bernardelli, et al.
Blood|December 12, 2022
Overlapping features of therapy-related and de novo NPM1-mutated AMLJad Othman, Manja Meggendorfer, Enrico Tiacci, et al.
The New England Journal of Medicine|June 14, 2011
BRAF mutations in hairy-cell leukemiaEnrico Tiacci, Vladimir Trifonov, Gianluca Schiavoni, et al.
Blood Cancer Journal|July 19, 2022
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian studyLivio Pagano, Marianna Criscuolo, Alessandro Broccoli, et al.
Haematologica|August 29, 2020
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06Chiara Caprioli, Federico Lussana, Silvia Salmoiraghi, et al.
Haematologica|December 24, 2002
Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patientsPier Luigi Zinzani, Maurizio Martelli, Marilena Bertini, et al.
Pageof 25